When Routine Testing Doesn't Answer the Clinical Question, Know What to Investigate Next.
Reficio helps clinicians navigate from routine investigations to appropriate advanced biomarkers, molecular diagnostics and genomics when clinically relevant — while the treating physician remains in control of diagnosis and treatment.
How Reficio Enters the Diagnostic Journey
A structured diagnostic continuum designed to support your clinical decision tree at every step.
Patient Presents
Symptom onset, clinical presentation, and history taking.
Clinical Question
Clinician identifies the diagnostic hypothesis to verify.
Routine Investigations (Tier 1)
CBC, organ chemistry, metabolic screening, baseline tests.
Standard Clinical Care
Treating doctor initiates evidence-based treatment, lifestyle recommendations, or standard periodic monitoring.
Reficio Escalates to the Appropriate Diagnostic Layer
Rather than unguided testing, Reficio structures the next logical tier proportional to the clinical presentation:
When the First Test Isn't the Whole Answer
Common clinical scenarios where stepped investigation pathways prevent diagnostic delays.
Persistent or Unexplained Clinical Findings
Unexplained fatigue, persistent arthralgia, or chronic elevated ESR/CRP with normal initial routine blood counts.
Tier 1 Baseline → Tier 2 Autoantibody & Specific Inflammatory Cascades
Conflicting or Inconclusive Investigation Results
Borderline endocrine parameters with overt clinical symptoms, or discordant free hormone fractions.
Tier 1 Screening → Tier 2/3 Method-Specific Free Fractions & Autoantibody Titers
Need for Deeper Molecular Characterisation
Confirmed infectious or oncological presentation requiring targeted genotype or resistance profiling.
Tier 1/2 Baseline → Tier 3 Targeted RT-PCR / Single-Gene Mutation Assays
Hereditary & Familial Genomic Risk Questions
Early-onset family cancer clustering or complex syndromic pediatric presentation requiring genomic evaluation.
Tier 1/2 Routine Workup → Tier 4/5 Germline NGS Panels or Clinical Exome Sequencing
What Changes for Your Practice?
Clear clinical benefits without administrative overhead or loss of patient continuity.
Save Search Time
Navigate a structured 781-investigation directory and multigene panels instead of independently searching across fragmented laboratory options.
Access Greater Diagnostic Depth
Move seamlessly from routine biochemistry toward specialised molecular and genomic testing when clinically appropriate.
One Coordinated Pathway
Rely on dedicated coordination for test selection, sample collection logistics, verified lab processing, and timely report delivery.
You Retain Clinical Control
The treating physician remains solely responsible for interpretation, diagnosis, and all patient management decisions.
Value Across the Care Continuum
How structured diagnostic orchestration supports patients, physicians, and clinical institutions simultaneously.
Clear, Connected Testing
- Clearer testing journey with transparent sample requirements.
- Less confusion around specialized and rare investigations.
- Access to appropriate advanced testing pathways without referral dead-ends.
- All reports return directly into clinician-led ongoing care.
Clinical Depth & Control
- Structured investigation navigation across 781 catalogue tests.
- Seamless escalation to advanced biomarkers, PCR, and NGS panels.
- Significantly reduced administrative coordination and lab chasing.
- Complete retention of diagnostic and therapeutic authority.
Institutional Menu Expansion
- Offer specialised and molecular testing without internal capital outlay.
- Keep patient diagnostics and follow-up within the institutional ecosystem.
- Standardised referral, sample transport, and reporting workflow.
- Opportunity to introduce modern genomic service lines seamlessly.
More Than a Test Catalogue
Traditional diagnostic portals offer passive search lists. Reficio provides an active clinical orchestration engine.
“Reficio connects diagnostic discovery, clinical context, advanced testing access and clinician-led follow-through in one structured journey.”
Where Genomics Adds Another Layer
We position next-generation sequencing as a purposeful clinical tool for specific indications — not as generic hype.
Routine Chemistry
Examines standard circulating biochemical markers, enzymes, and cell morphology.
Advanced Biomarkers
Investigates autoimmune antibodies, free hormone fractions, and specialized proteins.
Molecular (RT-PCR)
Targeted single-gene mutations, pathogen identification, and viral load quantification.
NGS & Genomics
Examines hundreds of genetic regions simultaneously for oncology, hereditary risk, or rare Mendelian presentations.
Show Me the Diagnostic Pathway
Select a common clinical presentation to see how Reficio structures investigations from routine baseline to advanced biomarkers and molecular genomics.
When inflammatory symptoms or joint pain persist despite non-specific routine findings.
Clinical Context: Persistent joint stiffness, unprovoked fatigue, multi-system inflammation, or elevated ESR/CRP with inconclusive initial workup.
Tier 1 — Routine Baseline
Assess non-specific inflammatory activity and baseline organ parameters.
Tier 2/3 — Specialised Biomarkers
Establish autoantibody specificity and connective tissue involvement.
Tier 4/5 — Molecular & NGS (If Indicated)
For suspected monogenic autoinflammatory syndromes or refractory pediatric onset.
Have a Patient Who Needs a Deeper Diagnostic Work-Up?
Tell us the clinical requirement. Reficio can help identify and coordinate the appropriate testing pathway while you remain in control of clinical decision-making.
Represent a Clinic, Hospital, or Department?
Establish an institutional testing arrangement for your oncology, rheumatology, or neurology wings without in-house capital expenditure.
Explore Institutional Partnerships →Clinician Diagnostic Enquiry
Submit a patient requirement or request test specifications for your practice.